Visual Performance With Clareon® Vivity® Intraocular Lenses (IOLs)

Completed · Not applicable

Conditions studied: Astigmatism

In brief

The purpose of this study is to generate clinical data to quantify the impact of residual astigmatism on the overall visual performance during distance, intermediate, and near viewing in patients implanted with Clareon Vivity IOLs.

Key facts

Study ID

NCT06784063

Run by

Alcon Research

People needed

40

Starts

2025-04-10

Expected to finish

2025-06-13

Last updated by the study team

2026-07-13

Who can join

Age: 22 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Able to understand and sign an Institution Review Board-approved informed consent form;
• Willing and able to attend all scheduled study visits as required by the protocol;
• Implanted with study IOLs in both eyes at least 4 months prior to study participation;
• Best Corrected Distance Visual Acuity (BCDVA) of 0 logarithm minimum angle of resolution (logMAR) or better in each eye.

You may not qualify if…

• Residual astigmatism greater than or equal to 1.00 diopter (D);
• Clinically significant ocular conditions as specified in the protocol;
• History of ocular surgeries other than limbal relaxing incisions
• Other protocol-specified exclusion criteria may apply.

Where it is running

• Grosinger, Spigelman & Grey Eye Surgeons, P.C — Bloomfield Hills, Michigan, United States
• Key-Whitman Eye Center — Dallas, Texas, United States
• Berkeley Eye Center — Sugar Land, Texas, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.